South Korea Antifungal Drugs Market Size & Outlook
The antifungal drugs market in South Korea is expected to reach a projected revenue of US$ 157.5 million by 2033. A compound annual growth rate of 3.9% is expected of South Korea antifungal drugs market from 2026 to 2033.
Revenue, 2025 (US$M)
$116.7
Forecast, 2033 (US$M)
$157.5
CAGR, 2026 - 2033
3.9%
Report Coverage
South Korea
Related Markets
South Korea antifungal drugs market highlights
- The South Korea antifungal drugs market generated a revenue of USD 116.7 million in 2025 and is expected to reach USD 157.5 million by 2033.
- The South Korea market is expected to grow at a CAGR of 3.9% from 2026 to 2033.
- In terms of segment, azoles was the largest revenue generating drug class in 2025.
- Echinocandins is the most lucrative drug class segment registering the fastest growth during the forecast period.
Antifungal drugs market data book summary
| Market revenue in 2025 | USD 116.7 million |
| Market revenue in 2033 | USD 157.5 million |
| Growth rate | 3.9% (CAGR from 2026 to 2033) |
| Largest segment | Azoles |
| Fastest growing segment | Echinocandins |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Azoles, Echinocandins, Polyenes, Allylamines |
| Key market players worldwide | Novartis AG ADR, Pfizer Inc, Bayer AG, Sanofi SA, Merck KGaA, Merck & Co Inc, GlaxoSmithKline, Abbott Laboratories, Enzon Pharmaceuticals Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals |
Other key industry trends
- In terms of revenue, South Korea accounted for 0.7% of the global antifungal drugs market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan antifungal drugs market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,710.7 million by 2033.
Azoles was the largest segment with a revenue share of 50.56% in 2025. Horizon Databook has segmented the South Korea antifungal drugs market based on azoles, echinocandins, polyenes, allylamines covering the revenue growth of each sub-segment from 2021 to 2033.
Key companies in the country are strategically engaged in the launch of new products. For instance, in recent years, Fugacil Lab launched Fugacil nail fungal treatment in South Korea. Thus, all such strategic initiatives are expected to support market growth in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antifungal Drugs Market Scope
Antifungal drugs market segmentation & scope
Antifungal Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Glenmark Pharmaceuticals | View profile | 10001+ | Andheri, Maharashtra, India, Asia | http://www.glenmarkpharma.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Enzon Pharmaceuticals Inc | View profile | 1 | 20 Commerce Drive, Suite 135, Cranford, NJ, United States, 07016 | http://www.enzon.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
South Korea antifungal drugs market size, by drug class, 2021-2033 (US$M)
South Korea Antifungal Drugs Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
